SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Item 5.07 discloses the results of Custom Truck One Source's June 11, 2026 annual stockholder meeting, including voting outcomes for the election of three Class A directors (Paul Bader, Mark D. Ein, and David Glatt) and ratification of Ernst & Young LLP as independent auditor. The tabulated vote counts and approval of all proposals are the core disclosure required under Item 5.07.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure of shareholder vote results from the 2026 Annual Meeting held on June 11, 2026. The filing reports final voting outcomes on three proposals: election of Class III directors (Proposal No. 1), advisory vote on named executive officer compensation (Proposal No. 2), and ratification of Deloitte & Touche LLP as independent auditor (Proposal No. 3), with detailed vote tallies certified by the Inspector of Elections. Shareholder voting outcomes are material to investors as they determine board composition and affirm governance decisions.
View raw filing on EDGAR →Bally's Intralot (59.44% owned by Bally's Corp) has entered into a definitive Cooperation Agreement to acquire all ordinary shares of Evoke PLC in an all-stock transaction valued at approximately £243.1 million. The acquisition is structured as a scheme of arrangement and is conditional on shareholder approvals and regulatory clearances. This is a material acquisition that would substantially affect the registrant's business and financial position.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from an annual meeting of security holders, as required by Item 5.07. The filing reports results on four proposals: setting board size at seven directors, electing seven directors (with individual vote tallies for each nominee), a non-binding advisory vote on named executive officer compensation, and ratification of the independent auditor (WithumSmith+Brown, PC). The disclosure is material as it reflects shareholder approval of board composition and governance matters.
View raw filing on EDGAR →Cabaletta Bio held its Annual Meeting of Stockholders on June 9, 2026, at which stockholders voted on and approved six proposals: election of two Class I directors (Scott Brun, M.D. and Shawn Tomasello, MBA), ratification of Ernst & Young LLP as auditor, approval of a charter amendment increasing authorized common shares from 300 million to 600 million, an advisory vote on named executive officer compensation, and approval of an adjournment proposal.
View raw filing on EDGAR →CoreWeave announced a $3.5 billion senior notes offering intended for debt financing and general corporate purposes, including repayment of outstanding indebtedness. While this is a material capital-raising event affecting the registrant's financial structure, it does not fit cleanly into the taxonomy's more specific categories (ma_activity applies to acquisitions/dispositions, not debt issuances; dilutive_issuance applies to equity). The disclosure is material to investors as it signals significant leverage activity and refinancing strategy.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from Remitly's June 10, 2026 Annual Meeting of Stockholders under Item 5.07. The filing reports voting outcomes on three proposals: election of directors (Bora Chung, Laurent Le Moal, and Nigel Morris), advisory approval of executive compensation, and ratification of PricewaterhouseCoopers LLP as independent auditor. All three proposals passed with substantial majorities, making this a material governance event that affects investor understanding of board composition and executive accountability.
View raw filing on EDGAR →Porch Group's subsidiary Porticus entered into a Securities Purchase Agreement with the Porch Reciprocal Exchange to acquire 2,092,050 shares of Porch common stock for approximately $15 million on June 10, 2026. The transaction represents a material share repurchase affecting the company's capital structure, treasury stock position, and share count.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from Instil Bio's 2026 Annual Meeting of Stockholders held on June 11, 2026. The filing reports voting outcomes for two proposals: (1) election of Class II directors George Matcham and Neil Gibson, and (2) ratification of RSM US LLP as the independent auditor. The disclosure includes vote tallies (votes for, against, withheld, and broker non-votes), which is the hallmark of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from Immuneering's Annual Meeting of Stockholders held on June 11, 2026, covering the election of two Class II directors (Peter Feinberg and Laurie B. Keating) and ratification of RSM US LLP as independent auditor. The filing explicitly states the vote tallies and outcomes for each proposal, which is the core content of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →DoorDash held its annual meeting of stockholders on June 10, 2026. Shareholders voted on and approved three proposals: election of four Class III directors, ratification of KPMG LLP as independent auditor, and advisory approval of named executive officer compensation, all with substantial majorities.
View raw filing on EDGAR →The filing discloses quarterly financial results for the quarter ended March 28, 2026 via a press release furnished as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition). This is a standard earnings release disclosure, which is material to investors assessing the registrant's operational and financial performance.
View raw filing on EDGAR →The Board authorized an additional $31.4 million share repurchase, bringing total authorized repurchases to $40 million. While share repurchase authorizations are routine capital allocation decisions, the magnitude ($31.4 million incremental authorization) and the disclosure in Item 8.01 suggest the company views this as material to investors' understanding of capital deployment strategy. However, this does not fit neatly into the more specific event categories (it is not a dilutive issuance, M&A activity, or executive compensation), so "other_material" is most appropriate.
View raw filing on EDGAR →Copley Acquisition Corp (a SPAC) entered into a Business Combination Agreement with Ignite Proteomics, LLC involving a two-step merger structure resulting in Ignite becoming a wholly-owned subsidiary of Pubco. The transaction contemplates $150 million in merger consideration paid in Pubco Common Stock plus a $4 million sponsor payment, with Pubco becoming a publicly traded company upon completion.
View raw filing on EDGAR →The filing discloses the appointment of Ms. Craig to the Board of Directors via press release issued on June 11, 2026. Board appointments are material events affecting the composition and governance of the registrant and would inform a reasonable investor's assessment of the company's leadership and oversight structure.
View raw filing on EDGAR →Amendment No. 7 to the company's credit agreement added $50 million in incremental revolving loans and modified financial covenants, including replacement of a first lien leverage ratio with a total leverage ratio of 4.00:1.00. The covenant modification suggests potential financial stress or preparation for a material transaction, though no traditional M&A event is disclosed.
View raw filing on EDGAR →The PIPC announced approximately $410 million in aggregate administrative fines against Coupang Corp. for data protection violations, including a previously disclosed November 2025 data incident and separate violations related to third-party advertising data collection. The company disclosed it will recognize these fines in Q2 2026 operating results and pursue judicial review in Seoul Administrative Court. This represents a material regulatory enforcement action with substantial financial consequences that would affect a reasonable investor's assessment of the company's financial condition and regulatory exposure.
View raw filing on EDGAR →Xeris Biopharma is issuing shares of common stock in a private placement to noteholders exchanging approximately $23 million in principal amount of convertible notes under Section 4(a)(2) exemptions, representing a dilutive equity issuance that materially affects shareholder ownership.
View raw filing on EDGAR →Xeris Biopharma has entered into Exchange Agreements with noteholders, announced on June 11, 2026, involving material corporate transactions and exchange consideration that materially affect investors.
View raw filing on EDGAR →This Item 5.07 filing discloses the final results of the June 10, 2026 annual meeting of stockholders, including voting outcomes for three proposals: election of Class III directors (Aina E. Konold, Kristy Pipes, and Brian Ames), ratification of KPMG LLP as independent auditor, and advisory approval of named executive officer compensation. The disclosure of shareholder vote results at an annual meeting is a core shareholder_vote_results event, and the outcomes are material to investors assessing board composition and governance.
View raw filing on EDGAR →McGraw Hill issued a press release on June 11, 2026 announcing financial results for the fiscal fourth quarter and fiscal year ended March 31, 2026.
View raw filing on EDGAR →The board approved a $50.0 million share repurchase plan on June 2, 2026, signaling management confidence in valuation and affecting capital deployment.
View raw filing on EDGAR →Venture Global's wholly-owned subsidiary VGLNG completed a $2.25 billion senior secured notes offering and used proceeds to redeem existing debt, representing a material refinancing transaction affecting the company's capital structure.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from the Company's Annual Meeting of Stockholders held on June 9, 2026. The filing reports the results of two proposals: (1) election of seven directors, with detailed vote tallies for each nominee, and (2) ratification of EY as independent auditor. This is a textbook Item 5.07 disclosure and is material as it reflects stockholder approval of board composition and auditor appointment.
View raw filing on EDGAR →American Airlines Group held its 2026 Annual Meeting on June 10, 2026, with shareholders voting on seven proposals including election of all 12 director nominees (passed with substantial majorities), ratification of KPMG as independent auditor, advisory approval of executive compensation, and several governance proposals.
View raw filing on EDGAR →Shareholders approved an amended and restated 2023 Incentive Award Plan that increases shares reserved for issuance by 16.5 million shares and modifies tax withholding provisions, directly affecting equity grant structures for officers and directors.
View raw filing on EDGAR →The filing discloses the death of William R. Berkley, the Company's founder and Executive Chairman, which is a material departure of a senior executive. While the section also mentions the appointment of W. Robert Berkley, Jr. as Chairman, the principal disclosed event centers on the founder's passing and the succession arrangement that follows, making this fundamentally an executive departure event.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from BRT Apartments Corp.'s annual meeting held on June 10, 2026. The filing presents detailed vote tallies for four proposals: election of directors (Carol Cicero, Frederic H. Gould, Gary Hurand, and Elie Weiss), advisory vote on executive compensation, ratification of Ernst & Young LLP as independent auditor, and approval of the 2026 Incentive Plan. All proposals were approved, making this a standard shareholder_vote_results disclosure under Item 5.07.
View raw filing on EDGAR →The Compensation Committee approved a $90,000 cash increase in annual compensation for Jeffrey D. Yowell, the Executive Chairman, effective June 1, 2026, bringing his total annual compensation to $340,000. This is a direct disclosure of a compensatory arrangement modification for a named executive officer, which falls squarely within the exec_compensation category. The materiality is supported by the magnitude of the increase and the fact that it was formally approved by the Committee.
View raw filing on EDGAR →The filing announces Kewaunee Scientific's plan to release fourth quarter and fiscal year 2026 financial results on June 23, 2026. Although the actual earnings results are not yet disclosed in this 8-K, the announcement of an imminent earnings release for a full fiscal year is a material event that would affect investor expectations and trading. The press release is furnished as Exhibit 99.1, consistent with earnings announcement disclosures.
View raw filing on EDGAR →Oxford Industries issued a press release on June 10, 2026 announcing financial results for fiscal 2026 first quarter ended May 2, 2026, filed under Item 2.02 (Results of Operations and Financial Condition). This is a standard quarterly earnings release disclosure, which is material to investors assessing the company's operational performance and financial condition.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure presenting the final voting results from Ascent Industries' Annual Meeting of Shareholders held June 10, 2026. The filing reports tabulated votes for three proposals: election of seven directors, advisory approval of named executive officer compensation, and ratification of Baker Tilly US, LLP as independent auditor. All results are presented in standard vote-count format (For, Against, Abstain, Broker Non-Votes), which is the hallmark of shareholder_vote_results classification.
View raw filing on EDGAR →The filing discloses results of a shareholder vote at the Annual Meeting of Shareholders on June 10, 2026, where the Board of Directors was re-elected in its entirety. This is a classic shareholder_vote_results disclosure under Item 5.07, and board re-election is material to investors as it affects corporate governance and oversight.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from Valaris Limited's 2026 Annual General Meeting held on June 10, 2026. The filing reports voting outcomes on three matters: election of six directors (Elizabeth D. Leykum, Anton Dibowitz, Dick Fagerstal, Joseph Goldschmid, Catherine J. Hughes, and Kristian Johansen), advisory approval of named executive officer compensation, and appointment of KPMG LLP as independent auditor. This is a quintessential Item 5.07 disclosure with detailed vote tallies (For, Against, Abstain, Non-Votes) for each proposal.
View raw filing on EDGAR →Werner Enterprises entered into Amendment No. 3 to its Loan and Security Agreement on June 5, 2026, increasing the maximum funding limit from $325 million to $350 million with potential increase to $400 million, and adding a Performance Guaranty by the parent company. This material amendment to the company's credit facility affects its capital structure and liquidity.
View raw filing on EDGAR →The filing discloses preliminary assets under management (AUM) as of May 31, 2026 via a news release furnished under Regulation FD Disclosure. While AUM is a key operational metric for asset managers that investors monitor, this disclosure does not fit cleanly into the standard event taxonomy (not earnings, M&A, executive changes, impairments, etc.). The materiality depends on whether the AUM figures represent significant changes, but the disclosure itself—a routine monthly/quarterly AUM announcement—is a standard practice for asset managers and may be administrative rather than material in the strict sense.
View raw filing on EDGAR →Colin M. Adams was elected as a director of Sleep Number's Board effective immediately on June 4, 2026, increasing the Board to 7 members with 6 independent directors. This is a clear executive appointment event. While the disclosure also mentions his compensation arrangement ($40,000 monthly fee), the principal action disclosed is the appointment itself, not a compensation arrangement modification.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure of shareholder vote results from FCX's 2026 annual meeting held on June 10, 2026. The filing reports final voting tallies for three proposals: election of eleven directors, advisory approval of named executive officer compensation, and ratification of Ernst & Young LLP as independent auditor. All three proposals passed with substantial majorities, and the disclosure includes detailed vote counts (for, against, abstentions, and broker non-votes) for each director nominee and proposal, which is the standard format for shareholder meeting results disclosures.
View raw filing on EDGAR →This is a clear Item 5.07 disclosure of shareholder vote results from Credit Acceptance's June 10, 2026 Annual Meeting of Shareholders. The filing reports voting outcomes on three proposals: election of six directors, advisory approval of named executive officer compensation, and ratification of Grant Thornton LLP as independent auditor. The detailed vote tallies (For, Against, Abstain, Broker Non Votes) for each proposal are the core content of the filing, making this unambiguously a shareholder_vote_results event that is material to investors assessing board composition and governance.
View raw filing on EDGAR →Joseph Billante was elected and appointed as Chief Financial Officer effective July 27, 2026, succeeding retiring CFO Jay D. Martin. The disclosure includes Billante's background and compensation package as part of the appointment.
View raw filing on EDGAR →HNI entered into Amendment No. 3 to its Credit Agreement on June 10, 2026, providing a new $498.75 million tranche of term loans maturing in 2032 to refinance all outstanding Initial Tranche B Term Loans, representing a material modification to the company's capital structure and debt obligations.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure reporting the final voting results from Biogen's June 9, 2026 Annual Meeting of Stockholders. The filing presents detailed vote tallies for three matters: election of ten directors, ratification of PricewaterhouseCoopers LLP as independent auditor, and advisory approval of executive compensation. These are routine but material shareholder governance matters that affect investor understanding of board composition and corporate oversight.
View raw filing on EDGAR →The filing discloses the Board's appointment of Anthony Vang as the Company's full-time Chief Financial Officer effective June 5, 2026. Although Mr. Vang has performed CFO duties since inception, the formal appointment to the CFO title is the principal disclosed action. This is material as it represents a formal governance change and clarifies the CFO role structure ahead of the Company's Nasdaq uplisting application.
View raw filing on EDGAR →InMed received a Nasdaq notice on March 27, 2026 that its closing bid price fell below the $1.00 minimum requirement under Nasdaq Listing Rule 5550(a)(2), creating delisting risk. Although the Company subsequently regained compliance by June 3, 2026, the disclosure centers on the failure to satisfy a continued listing rule and the remediation thereof—the core substance of delisting_risk. This is material to investors as it directly affects the registrant's exchange listing status.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from TeraWulf's June 9, 2026 Annual Meeting of Stockholders, covering three proposals: election of nine directors, advisory vote on executive compensation, and ratification of Deloitte as independent auditor. The filing presents detailed vote tallies for each proposal, which is the core content of Item 5.07 disclosures and is material to investors assessing corporate governance and board composition.
View raw filing on EDGAR →The filing discloses the dismissal of Bush & Associates CPA LLC as the Company's independent registered public accounting firm on June 10, 2026, and the appointment of DiPiazza LaRocca Heeter & Co., LLC as the new auditor effective for the fiscal year ending December 31, 2026. This is a classic auditor change under Item 4.01. While the prior auditor's reports contained a 'going concern' qualification, the primary disclosed event is the change in auditors itself, not the going concern matter (which is historical and already disclosed in prior filings).
View raw filing on EDGAR →The filing discloses a press release providing a "performance update as of and for the period ended May 31, 2026," which constitutes a financial results disclosure. Although filed under Item 7.01 (Regulation FD Disclosure) rather than the more typical Item 2.02, the substance is an earnings release—a periodic financial performance update material to investors' assessment of the registrant's operating results and financial condition.
View raw filing on EDGAR →This disclosure reports material regulatory approvals for the proposed merger between Paramount Skydance Corporation and Warner Bros. Discovery, Inc., including clearance from the Australian Competition and Consumer Commission (ACCC) and notifications from the New Zealand Commerce Commission (NZCC), along with approvals from multiple other competition and foreign direct investment authorities. The filing explicitly references the Agreement and Plan of Merger dated February 27, 2026, and describes the progression toward closing of this transformative transaction, making this a core M&A activity disclosure under Item 1.01/2.01 framework.
View raw filing on EDGAR →Celanese issued a notice of redemption for $4.777% Senior Notes due July 19, 2026, with redemption scheduled for June 25, 2026 at par plus accrued interest. While debt redemption is a routine capital management activity, the materiality depends on the principal amount outstanding (not disclosed here). The timing—redemption just before maturity—suggests refinancing or debt paydown activity that would be material to investors assessing the company's capital structure and liquidity, but the disclosure lacks sufficient detail to classify as a more specific event type.
View raw filing on EDGAR →Chubb INA Holdings agreed to sell C$800 million in senior notes (C$400M due 2031 at 3.780% and C$400M due 2033 at 4.034%), fully guaranteed by Chubb Limited. This is a material debt issuance that raises capital and increases financial obligations, but does not fit cleanly into the M&A, dilutive equity issuance, or other specific debt-related categories (covenant breach, going concern). The disclosure is material to investors assessing the registrant's capital structure and leverage.
View raw filing on EDGAR →